Phase III CONNEX trial in cognitive impairment in schizophrenia fails to meet primary and key secondary endpoints.
Datroway gains U.S. approval for treating metastatic HR-positive, HER2-negative breast cancer in previously treated patients.
Voluntary halt to all dosing in TROPOS trial of Cibotercept (KER-012) for pulmonary arterial hypertension by Keros Therapeutics.
HyBryte™ treatment for early-stage cutaneous T-cell lymphoma continues to demonstrate positive outcomes.
NMPA China approves Padcev and Keytruda for advanced urothelial cancer. Astellas Pharma.
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus, characterized by symptoms of esophageal dysfunction and an eosinophilic infiltrate. This guideline from the American College of Gastroenterology (ACG) provides comprehensive recommendations for the diagnosis and management of EoE.
FDA grants supplemental approval for Spravato nasal spray to treat major depressive disorder in adults.
FDA approves Lumakras with Vectibix for KRAS G12C-mutated metastatic colorectal cancer.
FDA approves 9mg and 22mg vials of Niktimvo (axatilimab) for chronic graft-versus-host disease treatment.